Home > Products > BCMA & TACI > Recombinant Human Anti-BCMA x Anti-TACI Bispecific Antibody (Tandem Fab)

Recombinant Human Anti-BCMA x Anti-TACI Bispecific Antibody (Tandem Fab)  (BSFAB-H199)

Recombinant Anti-BCMA x Anti-TACI Bispecific Antibody (Tandem Fab) is designed to be expressed as three chains derived from the variable domains of anti-BCMA and anti-TACI parental antibodies. It contains a His-tag for affinity purification. And the two Fd regions are connected by a flexible linker. This BsAb can bind two receptors simultaneously. It is designed for the research of Lymphoma therapy.

Specifications

Targets
BCMA & TACI
Type
Tandem Fab
Species Reactivity
Human
Target 1
BCMA
Host Animal 1
Human
Target 2
TACI
Host Animal 2
Human
Application
FuncS; Promising therapeutic agent
Related Disease
Lymphoma

Targets

Target 1
BCMA
Gene ID
UniProt ID
Alternative Names
TNFRSF17; tumor necrosis factor receptor superfamily, member 17; BCM; BCMA; CD269; TNFRSF13A; tumor necrosis factor receptor superfamily member 17; B-cell maturation factor; B cell maturation antigen; B-cell maturation protein
Target 2
TACI
Gene ID
UniProt ID
Alternative Names
TNFRSF13B; tumor necrosis factor receptor superfamily, member 13B; CVID; RYZN; TACI; CD267; CVID2; IGAD2; TNFRSF14B; tumor necrosis factor receptor superfamily member 13B; tumor necrosis factor receptor 13B; transmembrane activator and CAML interactor

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Human Anti-BCMA x Anti-TACI Bispecific Antibody (Tandem Fab) (BSFAB-H199). Click the button below to contact us or submit your feedback about this product.

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Welcome! For price inquiries, we will get back to you as soon as possible.

To order, please email

INQUIRY
Related products of "BCMA & TACI"
See other bsAb targets related to "BCMA"

Online Inquiry

24x7 Service quality
USA

Tel:
Fax:
Email:

UK

Tel:
Email:

Germany

Tel:
Email: